Greg Hannon Joins the New York Genome Center as Associate Core Member and Director of Cancer Genomics
The New York Genome Center (NYGC) welcomes Dr. Greg Hannon as Associate Core Member and Director of Cancer Genomics.
At NYGC Dr. Hannon will facilitate studies of cancer genomes, and run a research group focused on breast cancer and small RNA biology.
“Greg Hannon is one of the most creative minds today studying cancer genomics, and will be a tremendous asset to NYGC’s growth as a collaborative organization and to the collaborative consortium we are building in New York,” said Robert B. Darnell, NYGC’s President, CEO and Scientific Director. “His deep commitment, expertise and energy will help us reap the power of cancer genomic science to benefit of patients.”
Dr. Hannon has accepted numerous awards including the AACR Award for Outstanding Achievement in Cancer Research, the Pew Scholar in the Biomedical Sciences award, the National Academy of Sciences Award in Molecular Biology, the Memorial Sloan-Kettering Cancer Center Paul Marks Prize for Cancer Research and most recently the U.S. Army Breast Cancer Research Program Collaborative Scholars and Innovators Award.
Dr. Hannon is an advisor at The Artemis Project for a Preventive Breast Cancer Vaccine at the National Breast Cancer Coalition and a member of the Scientific Advisory Boards of the Memorial Sloan Kettering Cancer Center and the Institute of Molecular Biotechnology in Vienna.
Dr. Hannon is also the Royal Society Wolfson Research Professor at the Cancer Research UK Cambridge Institute at the University of Cambridge and an Adjunct Professor at Cold Spring Harbor Laboratory.
Dr. Hannon received his B.A. in Biochemistry and his Ph.D. in Molecular Biology at Case Western Reserve University.
About the New York Genome Center
The New York Genome Center (NYGC) is an independent, nonprofit at the forefront of transforming biomedical research and clinical care with the mission of saving lives. As a consortium of renowned academic, medical and industry leaders across the globe, NYGC focuses on translating genomic research into clinical solutions for serious disease. Our member organizations and partners are united in this unprecedented collaboration of technology, science, and medicine. We harness the power of innovation and discoveries to improve people’s lives – ethically, equitably, and urgently. Member institutions include: Albert Einstein College of Medicine, American Museum of Natural History, Cold Spring Harbor Laboratory, Columbia University College of Physicians and Surgeons, Cornell University/Weill Cornell Medical College, Hospital for Special Surgery, The Jackson Laboratory, Memorial Sloan- Kettering Cancer Center, Icahn School of Medicine at Mount Sinai, NewYork-Presbyterian Hospital, The New York Stem Cell Foundation, New York University, North Shore-LIJ, The Rockefeller University, Roswell Park Cancer Institute and Stony Brook University. For more information, visit: www.nygenome.org.